WebMar 8, 2024 · AveXis is investing an additional $60m in its new gene therapy manufacturing facility in Durham County, North Carolina, US. The facility was first announced in May 2024 and was estimated to cost $55m. The centre will enable the company to scale-up production of transformational therapies for rare neurological genetic diseases. WebTurbocharging gene therapies Back in 2024, when Novartis started its gene therapy production activities in Stein, the company not only faced the challenge to set up a state-of-the-art facility. It also needed to train staff to handle one of the most labor-intensive drug production efforts ever.
CAR-T Processing Facilities: Design Factors - BioProcess ...
WebApr 11, 2024 · On Tuesday, VintaBio revealed $64 million in financing and a new Philadelphia manufacturing facility. The young contract development manufacturing organization … Web1 purpose! Novartis expands its early development and innovative CAR-T cell therapy manufacturing capabilities in its newly launched Center of Excellence, located in the East Hanover, NJ campus. Our therapies are being developed as transformative treatments with life-saving potential for various B cell malignancies and other oncological diseases. We … simpec induction
Novartis shifting all gene therapy production to Durham
WebNov 11, 2024 · After completing an evaluation of its manufacturing site network, Swiss drugmaker Novartis (NYSE: NVS) has decided to shut down operations at a facility in Libertyville, Illinois, by the end of... WebApr 5, 2024 · The clearance of this milestone brings online the second commercially-licensed manufacturing facility for Novartis Gene Therapies, joining the Libertyville, Ill. site, which was approved for... WebTransformative gene therapy requires manufacturing excellence. Learn more about our cutting-edge process and precision equipment that allows us to reimagine… ravens wide receivers all time